SureTrader Advertisement
Home > Boards > US Listed > Medical - Drugs > Supernus Pharmaceuticals (SUPN)

1:21AM Supernus Pharma prices 10 mln share IP0

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 422
Posts 22,038
Boards Moderated 2
Alias Born 09/11/06
160x600 placeholder
Drugs - Generic Stocks Technical Snapshot - Sophiris Bio, Neurocrine Biosciences, Lannett, and Supernus Pharma "PR Newswire (US)" - 6/28/2016 8:25:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/24/2016 4:32:15 PM
Supernus Announces Issuance of Seventh U.S. Patent Protecting Oxtellar XR® "GlobeNewswire Inc." - 6/22/2016 4:30:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/17/2016 4:32:48 PM
Supernus Provides Update on Trokendi XR® Migraine sNDA and Reiterates Guidance "GlobeNewswire Inc." - 6/16/2016 4:30:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/3/2016 4:36:35 PM
Supernus Announces Issuance of Sixth U.S. Patent Protecting Oxtellar XR® "GlobeNewswire Inc." - 6/2/2016 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/25/2016 4:34:29 PM
Supernus to Present at June Jefferies Healthcare Conference "GlobeNewswire Inc." - 5/24/2016 5:16:13 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/19/2016 4:36:59 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 5/16/2016 2:01:49 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/10/2016 4:23:08 PM
Supernus Enters Into Partial Settlement Agreement with Actavis on Oxtellar XR® "GlobeNewswire Inc." - 5/10/2016 8:30:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/10/2016 6:06:22 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/4/2016 6:03:02 AM
Supernus Announces First Quarter 2016 Financial Results "GlobeNewswire Inc." - 5/3/2016 5:00:21 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/19/2016 5:25:22 PM
Supernus to Host First Quarter 2016 Earnings Conference Call "GlobeNewswire Inc." - 4/19/2016 12:01:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/12/2016 5:19:50 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/30/2016 5:59:16 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/24/2016 9:02:36 AM
Supernus Announces Record Fourth Quarter and Full Year 2015 Financial Results "GlobeNewswire Inc." - 3/9/2016 7:46:34 PM
Supernus to Present at March Cowen Health Care Conference "GlobeNewswire Inc." - 3/9/2016 7:46:16 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/4/2016 5:10:47 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/3/2016 6:25:49 PM
surf1944   Tuesday, 05/01/12 08:26:57 AM
Re: None
Post # of 120 
1:21AM Supernus Pharma prices 10 mln share IP0 at $5.00 per share, price in-line with expectations (SUPN) :

Supernus Pharmaceuticals (SUPN), a former Shire sub developing improved drug formulations for epilepsy and ADHD, plans to raise $55 million by offering 11.0 million shares at a price of $5.00. Supernus Pharmaceuticals will command a market value of $125 million. The Rockville, MD-based company, which was founded in 2005, plans to list on the NASDAQ under the symbol SUPN. Citi and Piper Jaffray (PJC) are the joint bookrunners on the deal.

http://seekingalpha.com/article/544941-6-ipos-planned-for-this-week?source=yahoo


surf's up......crikey



SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist